Vanguard Fiduciary Trust »

Entrada Therapeutics shares owned by Vanguard Fiduciary Trust

Quarter-by-quarter ownership of Entrada Therapeutics (TRDA) shares owned by Vanguard Fiduciary Trust from 13F filings

Historical chart of Vanguard Fiduciary Trust investment in Entrada Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Entrada Therapeutics held by Vanguard Fiduciary Trust consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Entrada Therapeutics by Vanguard Fiduciary Trust

Quarter filed Position value Share count Share price at filing
2026-03-31 $2.0M 157k 12.62

More positions owned by Vanguard Fiduciary Trust

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
Meta Platforms Cl A (META)
Tesla Motors (TSLA)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Eli Lilly & Co. (LLY)
JPMorgan Chase & Co. (JPM)
Exxon Mobil Corporation (XOM)
Johnson & Johnson (JNJ)
Wal-Mart Stores (WMT)

View all positions for Vanguard Fiduciary Trust

Top funds holding Entrada Therapeutics

Baker Bros. Advisors
5AM Venture Management
BlackRock
TCG Crossover Management
Vanguard Group
Vanguard Capital Management
Wellington Management Company
StepStone
Geode Capital Management
Millennium Management
State Street Corporation
Jones Hill Capital
Jacobs Levy Equity Management
Acadian Asset Management
Dimensional Fund Advisors

View all funds holding Entrada Therapeutics